These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15100325)

  • 1. Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis.
    Kimura T; Ishii Y; Morishima Y; Shibuya A; Shibuya K; Taniguchi M; Mochizuki M; Hegab AE; Sakamoto T; Nomura A; Sekizawa K
    J Immunol; 2004 May; 172(9):5782-9. PubMed ID: 15100325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
    Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH
    Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.
    Grabarz F; Aguiar CF; Correa-Costa M; Braga TT; Hyane MI; Andrade-Oliveira V; Landgraf MA; Câmara NOS
    Inflammopharmacology; 2018 Apr; 26(2):491-504. PubMed ID: 28779430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
    Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
    J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated accumulation of regulatory T cells and reduced production of interleukin 10 lead to the exacerbation of tissue injury in a mouse model of acute respiratory distress syndrome.
    Toyama M; Kudo D; Aoyagi T; Miyasaka T; Ishii K; Kanno E; Kaku M; Kushimoto S; Kawakami K
    Microbiol Immunol; 2018 Feb; 62(2):111-123. PubMed ID: 29266409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of bleomycin-induced pneumopathy by TNF.
    Kuroki M; Noguchi Y; Shimono M; Tomono K; Tashiro T; Obata Y; Nakayama E; Kohno S
    J Immunol; 2003 Jan; 170(1):567-74. PubMed ID: 12496444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.
    Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S
    Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells.
    Leite-De-Moraes MC; Hameg A; Pacilio M; Koezuka Y; Taniguchi M; Van Kaer L; Schneider E; Dy M; Herbelin A
    J Immunol; 2001 Jan; 166(2):945-51. PubMed ID: 11145671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of IL-4 in lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Phan SH
    J Immunol; 2003 Feb; 170(4):2083-92. PubMed ID: 12574379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.